Literature DB >> 12628330

Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique.

Shigeyuki Takada1, Yutaka Yamagata, Masafumi Misaki, Keiko Taira, Tomofumi Kurokawa.   

Abstract

Biodegradable microcapsules for sustained release of recombinant human growth hormone (rhGH) were prepared by a solid-in-oil-in-water (S/O/W) emulsion solvent evaporation technique using lyophilized protein microparticles. The minimum mean particle size of rhGH in S/O dispersions was 2.8-3.0 microm when ammonium acetate was added at molar ratios of 10-20 times against rhGH. High entrapment of rhGH in microcapsules was achieved by incorporating rhGH powder with a smaller particle size obtained by lyophilizing with ammonium acetate. As the particle size of rhGH decreased, the in vivo initial release decreased, while subsequent serum levels of rhGH in sustained release phase were higher. Addition of zinc oxide to microcapsules resulted in higher serum levels than those prepared without zinc oxide, suggesting a stabilizing effect of zinc oxide after subcutaneous injection into rats. The release profile of rhGH from microcapsules was controllable by selecting the proper copoly(DL-lactic/glycolic)acid (PLGA) with L/G ratio and molecular weight. Utilization of rhGH powder with a smaller particle size obtained by lyophilizing with ammonium acetate is essential for preparation of microcapsules with high entrapment and well-controlled sustained release profile with small initial release.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628330     DOI: 10.1016/s0168-3659(02)00494-7

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

1.  Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery.

Authors:  Tapan Kumar Giri; Chhatrapal Choudhary; Amit Alexander; Hemant Badwaik; Dulal Krishna Tripathi
Journal:  Saudi Pharm J       Date:  2012-05-26       Impact factor: 4.330

Review 2.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

3.  Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation.

Authors:  K D F Vlugt-Wensink; R de Vrueh; M G Gresnigt; C M Hoogerbrugge; S C van Buul-Offers; L G J de Leede; L G W Sterkman; D J A Crommelin; W E Hennink; R Verrijk
Journal:  Pharm Res       Date:  2007-10-11       Impact factor: 4.200

4.  Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique.

Authors:  Sabyasachi Maiti; Paramita Dey; Santanu Kaity; Somasree Ray; Sushomasri Maji; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2009-05-29       Impact factor: 3.246

5.  Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab.

Authors:  Sarath K Yandrapu; Arun K Upadhyay; J Mark Petrash; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-11-12       Impact factor: 4.939

6.  Initial Formation of the Skin Layer of PLGA Microparticles.

Authors:  Farrokh Sharifi; Andrew Otte; Kinam Park
Journal:  Adv Healthc Mater       Date:  2021-10-19       Impact factor: 11.092

7.  An Approach to the Design of a Particulate System for Oral Protein Delivery .II. Preparation and Stability Study of rhGH-Loaded Microspheres in Simulated Gastrointestinal Fluids.

Authors:  Nastaran Nafissi Varcheh; Reza Aboofazeli
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

Review 8.  Solid-in-Oil-in-Water Emulsion: An Innovative Paradigm to Improve Drug Stability and Biological Activity.

Authors:  Anali Sawant; Seema Kamath; Hemanth Kg; Girish Pai Kulyadi
Journal:  AAPS PharmSciTech       Date:  2021-07-01       Impact factor: 3.246

9.  Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.

Authors:  Stacie J Fairley; Shree R Singh; Abebayehu N Yilma; Alain B Waffo; Praseetha Subbarayan; Saurabh Dixit; Murtada A Taha; Chino D Cambridge; Vida A Dennis
Journal:  Int J Nanomedicine       Date:  2013-05-30

10.  The effects of technical and compositional variables on the size and release profile of bovine serum albumin from PLGA based particulate systems.

Authors:  B Taghipour; M Yakhchali; I Haririan; A M Tamaddon; S Mohammadi Samani
Journal:  Res Pharm Sci       Date:  2014 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.